DXRDAXOR CORP

Nasdaq daxor.com


$ 9.01 $ -0.30 (-3.39 %)    

Friday, 21-Jun-2024 14:31:35 EDT
QQQ $ 490.95 $ 4.06 (0.83 %)
DIA $ 392.84 $ -0.46 (-0.12 %)
SPY $ 551.46 $ 2.45 (0.45 %)
TLT $ 91.86 $ 1.19 (1.31 %)
GLD $ 217.99 $ 2.43 (1.13 %)
$ 8.54
$ 9.00
$ 0.00 x 0
$ 0.00 x 0
$ 8.90 - $ 9.01
$ 7.11 - $ 10.15
326
na
35.84M
$ 0.08
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-28-2012 12-31-2011 10-K
2 11-14-2011 09-30-2011 10-Q
3 08-09-2011 06-30-2011 10-Q
4 05-13-2011 03-31-2011 10-Q
5 03-29-2011 12-31-2010 10-K
6 11-12-2010 09-30-2010 10-Q
7 08-13-2010 06-30-2010 10-Q
8 05-11-2010 03-31-2010 10-Q
9 03-29-2010 12-31-2009 10-K
10 11-12-2009 09-30-2009 10-Q
11 08-13-2009 06-30-2009 10-Q
12 05-12-2009 03-31-2009 10-Q
13 03-23-2009 12-31-2008 10-K
14 11-13-2008 09-30-2008 10-Q
15 07-31-2008 06-30-2008 10-Q
16 05-15-2008 03-31-2008 10-Q
17 03-31-2008 12-31-2007 10-K
18 11-14-2007 09-30-2007 10-Q
19 08-09-2007 06-30-2007 10-Q
20 05-15-2007 03-31-2007 10-Q
21 04-02-2007 12-31-2006 10-K
22 11-15-2006 09-30-2006 10-Q
23 08-14-2006 06-30-2006 10-Q
24 05-22-2006 03-31-2006 10-Q
25 04-18-2006 12-31-2005 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 daxor-corporation-acquires-volumex-and-megatope-from-its-existing-supplier-along-with-glofil-to-enhance-existing-suite-of-diagnostics-no-financial-terms-disclosed

Expected to Improve Margins and Increase Revenue Streams Oak Ridge, TN, March 25, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (N...

 daxor-announces-as-of-december-31-2023-daxors-net-assets-were-34010384-or-708-per-share-revenue-increased-318-year-on-year-for-2023-versus-2022-provides-corporate-update-in-letter-to-shareholders

Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology today issued a corporate update in a L...

 daxor-announces-sales-to-three-new-hospitals-furthering-expansion-of-its-user-base

Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology today announces the expansion of blood...

 daxor-announces-two-significant-new-customer-transactions-with-the-cos-bva-100-in-january-no-financial-terms-disclosed

Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology today announces two significant new cu...

 daxor-corporation-closes-q4-2023-with-growth-in-new-sales-to-hospital-systems-and-increased-utilization-of-its-bva-100-blood-volume-diagnostic-across-the-us-at-existing-accounts

Daxor's ezBVA Lab Service Plays a Significant Role in Driving Growth and Fostering Widespread Adoption Oak Ridge, TN, Feb. ...

 daxor-announces-that-the-united-states-patent-and-trademark-office-has-issued-the-company-a-second-patent-safeguarding-a-distinctive-clinical-guidance-system-for-blood-volume-management

 This System Utilizes Unique Blood Volume Metrics And Related Clinical Measures To Create Support Guidance For Fluid Management...

 daxor-announces-it-has-submitted-its-blood-volume-analyzer-daxor-bva-to-the-fda

The New BVA System is Designed to be Significantly Faster, Simpler and Give Results at the BedsidePotential clearance is expect...

 daxor-corporation-awarded-new-patent-for-remote-monitoring-of-blood-volume

Patent Covers Novel Optimization of Care by Remote Monitoring Devices Including Smartwatches Oak Ridge, TN, Nov. 09, 2023 (GLOB...

 daxor-corp-announces-new-data-from-banner-university-medicine-demonstrating-effectiveness-of-bva-100-use-in-ambulatory-heart-failure-patients-presented-at-heart-failure-society-of-america-annual-scientific-meeting

Blood Volume Analysis (BVA) in 83-Patient Study Provided Highly Effective Guidance for Care of Heart Failure Patients Otherwise...

 daxor-corp-wins-support-from-the-national-institutes-of-health-nih-catalyze-preclinical-services-program

Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology, today announces it has been accepted ...

 daxor-corporation-announces-further-acquisitions-and-increased-utilization-of-its-bva-100-blood-volume-diagnostic-throughout-the-us

Daxor Adds a Six-Facility Hospital System with ezBVA Lab and Expands Treatment Areas Among Existing Accounts Oak Ridge, TN, Ju...

 daxor-corporation-awarded-11m-contract-from-the-us-defense-health-agency-for-added-capabilities-to-its-point-of-care-blood-volume-analyzer

Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology, today announced that the United State...

 why-zim-integrated-shipping-services-shares-are-trading-lower-by-14-here-are-other-stocks-moving-in-mondays-mid-day-session

Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the com...

 daxor-corporation-announces-pricing-of-4m-underwritten-public-offering-of-410260-shares-of-its-common-stock-at-a-price-of-975share

DAXOR CORPORATION (NASDAQ:DXR) ("Daxor", or the "Company"), the global leader in blood volume measurement techn...

 why-immix-biopharma-shares-are-trading-higher-by-around-45-here-are-20-stocks-moving-premarket

Gainers SeqLL Inc. (NASDAQ: SQL) shares surged 61.1% to $0.54 in pre-market trading after dropping 14% on Friday. SeqLL rece...

 new-study-demonstrates-clinical-utility-of-daxors-blood-volume-diagnostic-in-heart-failure-outcomes

Daxor's BVA Technology Shown to Provide Unique and Individualized Data for Patient Management Oak Ridge, TN, May 18, 2023 ...